Rockefeller Capital Management
CRL icon

Rockefeller Capital Management’s Charles River Laboratories CRL Stock Holding History

Rockefeller Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447K Buy
1,970
+231
+13% +$41.1K ﹤0.01% 2142
2026
Q1 		$300K Sell
1,739
-11
-0.6% -$2.04K ﹤0.01% 2258
2025
Q4 		$349K Buy
1,750
+404
+30% +$73.3K ﹤0.01% 2085
2025
Q3 		$211K Buy
+1,346
New +$214K ﹤0.01% 2208
2023
Q1 		– Sell
-861
Closed -$187K – 2359
2022
Q4 		$187K Sell
861
-211
-20% -$46.1K ﹤0.01% 1697
2022
Q3 		$210K Sell
1,072
-205
-16% -$44.3K ﹤0.01% 1627
2022
Q2 		$273K Buy
1,277
+225
+21% +$55K ﹤0.01% 1502
2022
Q1 		$297K Sell
1,052
-1,082
-51% -$334K ﹤0.01% 1533
2021
Q4 		$803K Sell
2,134
-371
-15% -$144K ﹤0.01% 1130
2021
Q3 		$1.03M Buy
2,505
+194
+8% +$80.6K 0.01% 993
2021
Q2 		$854K Buy
2,311
+152
+7% +$50.8K ﹤0.01% 986
2021
Q1 		$625K Buy
2,159
+1,721
+393% +$478K ﹤0.01% 953
2020
Q4 		$109K Buy
438
+45
+11% +$10.7K ﹤0.01% 1404
2020
Q3 		$88K Sell
393
-6
-2% -$1.25K ﹤0.01% 1304
2020
Q2 		$69K Sell
399
-77
-16% -$12.3K ﹤0.01% 1311
2020
Q1 		$60K Buy
476
+88
+23% +$13.2K ﹤0.01% 1181
2019
Q4 		$60K Sell
388
-542
-58% -$75K ﹤0.01% 1102
2019
Q3 		$123K Buy
930
+575
+162% +$77.1K ﹤0.01% 733
2019
Q2 		$50K Sell
355
-187
-35% -$25.4K ﹤0.01% 812
2019
Q1 		$79K Buy
542
+289
+114% +$38K ﹤0.01% 812
2018
Q4 		$29K Hold
253
– – ﹤0.01% 578
2018
Q3 		$34K Hold
253
– – ﹤0.01% 464
2018
Q2 		$28K Hold
253
– – ﹤0.01% 497
2018
Q1 		$27K Buy
+253
New +$27.3K ﹤0.01% 452

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Rockefeller Capital Management's CRL Position: Q2 2026 in Review

Rockefeller Capital Management increased its Charles River Laboratories (CRL) stake by 13% in Q2 2026, buying an estimated $41.1K and bringing the position to 1,970 shares worth $447K. The position accounts for ﹤0.01% of the portfolio, ranked #2142.

Rockefeller Capital Management first reported a position in CRL in Q1 2018 and has held it in 24 quarters since. The position peaked at $1.03M in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Rockefeller Capital Management held 1,970 shares of Charles River Laboratories worth $447K as of Q2 2026.
  • Rockefeller Capital Management bought 231 Charles River Laboratories shares in Q2 2026, an estimated $41.1K.
  • Charles River Laboratories made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2142 holding.
  • Rockefeller Capital Management first reported a position in Charles River Laboratories in Q1 2018 and has held it in 24 quarters since.
  • Rockefeller Capital Management's Charles River Laboratories position peaked at $1.03M in Q3 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.